deltatrials

Groupe Hospitalier de la Region de Mulhouse et Sud Alsace Clinical Trials

Sponsors / Groupe Hospitalier de la Region de Mulhouse et Sud Alsace

The ClinicalTrials.gov registry records 26 trials led by Groupe Hospitalier de la Region de Mulhouse et Sud Alsace. Across the portfolio, 2 are in recruitment, 1 are active non-recruiting, and 16 have reached completion. 6 trials have been terminated or withdrawn. The most common reasons cited for termination include slow or insufficient recruitment, investigator or site changes. Across the portfolio, planned enrollment totals 2,794 participants. Data on this page mirrors the ClinicalTrials.gov registry as of the most recent refresh.

26
Total Trials
2
Recruiting
1
Other Active
16
Completed
6
Terminated / Withdrawn
2,794
Total Enrollment

Termination reasons: Recruitment83% · PI/or_Site17%

Recent Terminations

  • NCT06399094 Stopped Aug 2025
    Chronic Obstructive Pulmonary Disease
    "Recruitment issue"
  • NCT05213845 Phase NA Stopped Jan 2023
    Low Back Pain
    "insufficient recruitment to meet the objectives in time"
  • NCT04827758 Phase NA Stopped Sep 2022
    Sarcopenia
    "insufficient recruitment to meet the objectives in time"
  • NCT04502927 Phase NA Stopped Mar 2020
    Muscle Spasticity
    "recruitement issues related to COVID-19"
  • NCT04732312 Stopped Oct 2019
    Age-related Cognitive Decline
    "recruitment issues"
  • NCT02946372 Phase NA Stopped Jun 2017
    Retinal Perforations
    "Principal investigator left the institution"

Active Trials (1 total)

Top Conditions

Top Locations